Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis
- First Online:
- 87 Downloads
The notion that oxidation of lipids and propagation of free radicals may contribute to the pathogenesis of atherosclerosis is supported by a large body of evidence. To circumvent the damage caused by oxygen free radicals, antioxidants are needed which provide the much needed neutralization of free radical by allowing the pairing of electrons. In this study we have investigated the effect of ascorbic acid, a water soluble antioxidant on the development of hypercholesterolemia induced atherosclerosis in rabbits. Rabbits were made hypercholesterolemic and atherosclerotic by feeding 100 mg cholesterol/day. Different doses of ascorbic acid were administered to these rabbits. Low dose of ascorbic acid (0.5 mg/100 g body weight/day) did not have any significant effect on the percent of total area covered by atherosclerotic plaque. However, ascorbic acid when fed at a higher dose (15 mg/100 g body weight/day) was highly effective in reducing the atherogenecity. With this dose the percent of total surface area covered by atherosclerotic plaque was significantly less (p < 0.001). This suggests that use of ascorbic acid may have great promise in the prevention of hypercholesterolemia induced atherosclerosis.
Keywordsascorbic acid atherosclerosis hypercholesterolemia
Unable to display preview. Download preview PDF.
- 3.Lipid Research Clinics program: The Lipid Research Clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease. JAMA 251 351–364, 1984.Google Scholar
- 4.Lipid Research Clinic Program: The Lipid Research Clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365–374, 1984.Google Scholar
- 7.Buchwald H, Varco RL, Matts JP: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of Hyperlipidemias (POSCH). N Engl J Med 323: 946–955, 1990.Google Scholar
- 15.Faggioto A, Ross R: Studies of hypercholesterolemia in non human primates. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4: 341–356, 1984.Google Scholar
- 22.Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725–7729, 1987.PubMedCrossRefGoogle Scholar
- 26.Viswanathan NM, Bhakthan NMG, Rockerbie RA: Effect of dietary supplementation of vitamin E on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vitamin Res 49: 370–375, 1979.Google Scholar
- 32.Steinberg D: Antioxidants in the prevention of human atherosclerosis. Circulation 85: 2338–2345, 1992.Google Scholar